These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35476502)

  • 1. Emerging proteoglycans and proteoglycan-targeted therapies in rheumatoid arthritis.
    Hurysz B; Bottini N
    Am J Physiol Cell Physiol; 2022 Jun; 322(6):C1061-C1067. PubMed ID: 35476502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.
    Markovics A; Ocskó T; Katz RS; Buzás EI; Glant TT; Mikecz K
    PLoS One; 2016; 11(7):e0160284. PubMed ID: 27466816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and Localization of Citrullinated Proteoglycan Aggrecan in Human Articular Cartilage.
    Glant TT; Ocsko T; Markovics A; Szekanecz Z; Katz RS; Rauch TA; Mikecz K
    PLoS One; 2016; 11(3):e0150784. PubMed ID: 26943656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis.
    Mânsson B; Gülfe A; Geborek P; Heinegård D; Saxne T
    Ann Rheum Dis; 2001 Jan; 60(1):27-31. PubMed ID: 11114278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis.
    Ishiguro N; Ito T; Oguchi T; Kojima T; Iwata H; Ionescu M; Poole AR
    Arthritis Rheum; 2001 Nov; 44(11):2503-11. PubMed ID: 11710706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis.
    Zou J; Zhang Y; Thiel A; Rudwaleit M; Shi SL; Radbruch A; Poole R; Braun J; Sieper J
    Rheumatology (Oxford); 2003 Jul; 42(7):846-55. PubMed ID: 12730543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis.
    Poole AR; Ionescu M; Swan A; Dieppe PA
    J Clin Invest; 1994 Jul; 94(1):25-33. PubMed ID: 7518830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
    Kaur S; White S; Bartold M
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling.
    Miao CG; Yang YY; He X; Li XF; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
    Cell Signal; 2013 Oct; 25(10):2069-78. PubMed ID: 23602936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy.
    Doody KM; Stanford SM; Sacchetti C; Svensson MN; Coles CH; Mitakidis N; Kiosses WB; Bartok B; Fos C; Cory E; Sah RL; Liu-Bryan R; Boyle DL; Arnett HA; Mustelin T; Corr M; Esko JD; Tremblay ML; Firestein GS; Aricescu AR; Bottini N
    Sci Transl Med; 2015 May; 7(288):288ra76. PubMed ID: 25995222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics.
    Glant TT; Finnegan A; Mikecz K
    Crit Rev Immunol; 2003; 23(3):199-250. PubMed ID: 14584879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis.
    Lohmander LS; Neame PJ; Sandy JD
    Arthritis Rheum; 1993 Sep; 36(9):1214-22. PubMed ID: 8216415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis.
    Glant TT; Mikecz K
    Methods Mol Med; 2004; 102():313-38. PubMed ID: 15286393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis.
    Saxne T; Heinegård D; Wollheim FA; Pettersson H
    Lancet; 1985 Jul; 2(8447):127-8. PubMed ID: 2862321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration of collagen, aggrecan and cartilage oligomeric matrix protein (COMP) in synovial fluid from equine middle carpal joints.
    Skiöldebrand E; Lorenzo P; Zunino L; Rucklidge GJ; Sandgren B; Carlsten J; Ekman S
    Equine Vet J; 2001 Jul; 33(4):394-402. PubMed ID: 11469774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial fluid concentrations of interleukin-1 beta and proteoglycans are inversely related.
    Saxne T; Di Giovine FS; Heinegård D; Duff GW; Wollheim FA
    J Autoimmun; 1988 Aug; 1(4):373-80. PubMed ID: 3266994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy.
    Ibáñez-Costa A; Perez-Sanchez C; Patiño-Trives AM; Luque-Tevar M; Font P; Arias de la Rosa I; Roman-Rodriguez C; Abalos-Aguilera MC; Conde C; Gonzalez A; Pedraza-Arevalo S; Del Rio-Moreno M; Blazquez-Encinas R; Segui P; Calvo J; Ortega Castro R; Escudero-Contreras A; Barbarroja N; Aguirre MA; Castaño JP; Luque RM; Collantes-Estevez E; Lopez-Pedrera C
    Ann Rheum Dis; 2022 Jan; 81(1):56-67. PubMed ID: 34625402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in cartilage proteoglycan aggrecan after intra-articular injection of interleukin-1 in rabbits: studies of synovial fluid and articular cartilage.
    Lundberg C; Asberg I; Ionescu M; Reiner A; Smedegård G; Poole AR
    Ann Rheum Dis; 1996 Aug; 55(8):525-34. PubMed ID: 8774180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.